Consolidated Statements of Stockholders’ Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 14	$ 201,697	$ 82,637,749	$ (83,479,932)	$ (640,472)
Balance (in Shares) at Dec. 31, 2018	13,602	201,697,396
Warrants issued with debt			263,237		263,237
Shares issued for services		$ 25			25
Shares issued for services (in Shares)		25,000
Sale of common stock		$ 4,847	849,152		853,999
Sale of common stock (in Shares)		4,846,666
Stock-based compensation expense			2,157,385		2,157,385
Net loss				(5,556,339)	(5,556,339)
Balance at Dec. 31, 2019	$ 14	$ 206,569	85,907,523	(89,036,271)	(2,922,164)
Balance (in Shares) at Dec. 31, 2019	13,602	206,569,062
Sale of common stock		$ 5,480	1,638,620		1,644,100
Sale of common stock (in Shares)		5,480,334
Cancellation of common stock		$ (31,000)	31,000
Cancellation of common stock (in Shares)		(31,000,000)
Purchase and cancellation of common stock		$ (5,000)	(1,495,000)		(1,500,000)
Purchase and cancellation of common stock (in Shares)		(5,000,000)
Stock issuance to pay off convertible notes and accrued interest		$ 18,386	5,497,466		5,515,852
Stock issuance to pay off convertible notes and accrued interest (in Shares)		18,386,174
Purchase and cancellation of common stock		$ (5,000)	(295,000)		(300,000)
Purchase and cancellation of common stock (in Shares)		(5,000,000)
Recognize beneficial conversion feature			919,000		919,000
Stock-based compensation expense			1,487,701		1,487,701
Restricted stock agreement-based non-cash compensation		$ 19	13,106		13,125
Restricted stock agreement-based non-cash compensation (in Shares)		18,750
Common stock issued on exercise of stock option and warrant		$ 1,075	74,175		75,250
Common stock issued on exercise of stock option and warrant (in Shares)		1,075,000
Net loss				(3,230,494)	(3,230,494)
Balance at Dec. 31, 2020	$ 14	$ 190,529	$ 93,778,591	$ (92,266,764)	$ 1,702,370
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320